E-briefings are published weekly and are listed below, with the most recent at the top. You may filter by topic and access dozens of additional articles using the page navigation below. Check back often to access new articles online or subscribe to have each new article delivered straight to your inbox weekly!
Two examples highlighting how decision-making tools are developing from curated genomic data to improve clinical implementation of precision medicine.
Where AI and molecular testing are showing new methods of detecting pancreatic cancers before they become more advanced.
Voice-Based Diagnostics Offers Potential Precision Medicine Advances as NIH Invests in Speech-Based Technologies
Research team identifies five disease cohort categories for which voice changes have been associated with specific diseases with well-recognized unmet needs.
Artificial Intelligence Accelerates Application of Precision Medicine for Incurable Neurological Diseases
Watching a new set of genes for ALS treatment connections, using remote sleep monitoring for detecting Parkinson’s breathing patterns, plus a major investment.
California to Become Sixth State to Cover Cancer Biomarker Testing, But Precision Medicine Screenings Are Not Included
More states are focusing on cancer biomarker testing for payer coverage requirements.
Precision Medicine and Microbiomics Are Related, New Research Finds Genetics Affects Bacteria in the Gut
New microbiome study shows that genes impact what types of bacteria are present in the intestines, creating new implications for neurological and emotional health.
Recent research into liquid biopsies has resulted in a new blood test that can detect liver cancer while it is still in an early stage.
Diagnostic yield in larger gene panel testing, ambitious goals for gene editing, and gauging demand for genetic testing in the community.
Several recent advances in wearable technologies may mean that healthcare leaders are getting closer to seeing wearables as a core part of precision medicine.
After a multimillion-dollar investment of public funding for early implementation of rapid whole genome sequencing (rWGS), those at the forefront release progress.